Palvella Therapeutics was founded with the single-minded goal of serving individuals suffering from serious rare genetic diseases with no approved treatments. By developing pathogenetically targeted therapies that address the root causes of these diseases.

Biotechnology

Education

Palvella Therapeutics

Wes Kaupinen

Matthew Korenberg

Alexis Lawthers

Sam Vuong

Kathleen McGowan

Jason Connor

Emily Cook

Kathy Goin

Jeff Martini

Braham Shroot

Advisory Team

Leadership Team

Clinical and Regulatory Operations

Management and Operations

Teams at Palvella Therapeutics

Advisory Team

Leadership Team

Clinical and Regulatory Operations

Management and Operations